Sponsors

Hyperviscosity syndrome: a complication hiding in plain sight?

David Manuel, David Norcliffe and Bernie Benson present a study of hyperviscosity syndrome, looking at its associated primary causes, along with the effects, symptoms and laboratory testing of this critical medical condition.

Plasma hyperviscosity, known as hyperviscosity syndrome (HVS), is a secondary condition which may occur in a considerable number of clinical conditions and sometimes not given
the same consideration as the primary cause. The fact that it can be a consequence of a primary condition does not reduce the importance of its effects or symptoms. Indeed, one of the initial symptoms is often identified during a routine eye examination by an optometrist. Treatment of the primary cause usually improves the HVS symptoms. 

Hyperviscosity syndrome is a critical medical condition which can present with a triad of neurological problems. It arises when the blood becomes so thick (viscous) that it cannot flow freely through the blood vessels.

This condition may occur due to an excess of red blood cells, white blood cells, or blood proteins. If left untreated, it may result in arterial blockages and diminished blood circulation to essential organs.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

Fresh muscle biopsies webinar

Online
11 December, 2025

POCT Innovators - The power to disrupt through diagnostics

National Army Museum, Chelsea, London
15 December, 2025

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026